GLPG5101
CD19
ATALANTA-1
CAR-T cell therapy
R/R NHL
Our Pipeline
Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules, CAR-T therapies, and biologics in oncology and immunology.
Oncology
Hemato-oncology
Product candidate
Target
Study
Drug class
Indication
Discovery
Ind-enabling
Phase 1
Phase 2
GLPG5201
CD19
EUPLAGIA-1
CAR-T cell therapy
R/R CLL/RT
GLPG5301
BCMA
PAPILIO-1
CAR-T cell therapy
R/R MM
Armored
bi-specific
bi-specific
Undisclosed
CAR-T cell therapy
Hematological tumor
Next-gen assets
Multiple
CAR-T cell therapy
Hematological tumor
Solid tumors
Product candidate
Target
Study
Drug class
Indication
Discovery
Ind-enabling
Phase 1
Phase 2
Uza-cel*
MAGE-A4
TCR-T cell therapy
Head & neck cancer
Next-gen assets
Multiple
Cell therapy
Solid tumors
pBIC assets
Multiple
Small molecule
Solid tumors
Immunology
Product candidate
Target
Study
Drug class
Indication
Discovery
Ind-enabling
Phase 1
Phase 2
GLPG3667
TYK2
GALACELAGALARISSO
Small molecule
SLEDM
pBIC candidate
Undisclosed
Small molecule
Inflammatory bowel disease
pBIC assets
Multiple
Small molecule
Inflammation/auto-immune disorders
*Subject to opt-in under collaboration and exclusive license agreement with Adaptimmune for uza-cel (ADP-A2M4CD8) (signed and announced on 30 May 2024)
CAR-T cell therapy, Chimeric antigen receptor T cell therapy; TCR-T cell therapy, T cell receptor T cell therapy; R/R NHL, Relapsed/refractory non-Hodgkin lymphoma; R/R CLL/RT, Relapsed/refractory chronic lymphocytic leukemia and Richter transformation; R/R MM, Relapsed/refractory multiple myeloma; SLE, Systemic lupus erythematosus; DM, Dermatomyositis;
Visit our Clinical Trials Portal
Clinical trials are a critical part of our journey to evaluate investigational treatments and gain approval from health authorities such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
At Galapagos, we organize clinical trials in various therapeutic areas, conducting research that paves the way for innovative solutions.
Visit our Clinical Trials portal to explore the fascinating world of clinical trials. Discover how they’re set up and gain insight into what’s important when considering participation.
Our stories
More about our company, science and people
We curate a series of inspiring stories about how we are #LivingInnovation at Galapagos
Partnerships
Work with us!
We are adding new capabilities, technologies and product candidates through internal and external innovation. Let’s start #PioneeringForPatients, together!
Investor Hub
All information for investors…
… centralized in one Investor Hub. Discover how we aim to create value for all our stakeholders.